Aradigm Corporation Announces Fourth Quarter 2014 And Full Year Financial Results

HAYWARD, Calif.--(BUSINESS WIRE)--Aradigm Corporation (NASDAQ:ARDM) (the “Company”) today announced financial results for the fourth quarter and full year ended December 31, 2014. Fourth Quarter 2014 Results The Company recorded $8.1 million in revenue in the fourth quarter of 2014 compared with $4.6 million in revenue in the fourth quarter of 2013. Total operating expenses for the fourth quarter of 2014 were $8.9 million, compared with total operating expenses of $4.9 million for the fourth quarter of 2013. The increase in operating expenses was primarily due to higher research and development expenses related to the Pulmaquin® inhaled ciprofloxacin program. The Company’s net loss for the fourth quarter of 2014 was $0.8 million, or $0.06 per share, compared with a net loss of $0.7 million, or $0.04 per share, for the same period in 2013.

Help employers find you! Check out all the jobs and post your resume.